Alopecia Treatment Market Report 2025: For Strategy Officers and Market Intelligence Teams

June 16, 2025 09:46 PM AEST | By EIN Presswire
 Alopecia Treatment Market Report 2025: For Strategy Officers and Market Intelligence Teams
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, June 16, 2025 /EINPresswire.com/ -- What Does The Data On The Alopecia Treatment Market Size Indicate?
Driven by an increasing prevalence of hair loss and rising awareness about hair loss treatments, the alopecia treatment market size has witnessed robust growth in recent years. The market was valued at $9.56 billion in 2024 and is projected to reach $10.22 billion in 2025, showing a compound annual growth rate CAGR of 6.9%. Factors such as aging population, hormonal changes, genetic predisposition, and growth in cosmetic and dermatology industries, along with improved healthcare access, have significantly contributed to this rise.

What Will The Alopecia Treatment Market Size Be Going Forward?
The market is poised for steady growth in the future. The alopecia treatment market is forecasted to rise to $13.22 billion by 2029 at a CAGR of 6.7%. This growth can be ascribed to an increasing adoption of non-invasive treatments, a growing demand for personalized medicine, and a rising focus on mental health and self-esteem. Furthermore, the accelerating consumer awareness about hair loss causes and treatments as well as increasing clinical trials for alopecia therapies are expected to boost the market growth. Among the significant trends in the forecast period are advancements in stem cell-based hair regeneration, use of platelet-rich plasma PRP therapy, development of jake inhibitors for autoimmune alopecia, innovations in laser hair therapy, and the introduction of wearable devices for hair growth stimulation.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24140&type=smp

What Are The Principal Drivers For Growth Of The Alopecia Treatment Market?
A growing prevalence of hair loss is a key driving factor behind the growth of the alopecia treatment market. Hair loss, marked by a partial or complete loss of hair from the scalp or other parts of the body, is increasingly prevalent due to higher stress levels, which can disrupt the normal hair growth cycle and trigger conditions like telogen effluvium, leading to excessive hair shedding. As more individuals seek effective solutions to manage and reverse hair loss, the demand for advanced and accessible alopecia treatments is on the rise. For example, as per the American Academy of Dermatology's report in October 2024, about 80 million Americans, including 50 million men and 30 million women, were affected by hair loss. Hence, the escalating prevalence of hair loss is anticipated to fuel the growth of the alopecia treatment market.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/alopecia-treatment-global-market-report

Who Are The Leading Players In The Alopecia Treatment Market?
Key players in this market include Pfizer Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Inc., Incyte Corporation, Hims & Hers Health Inc., Bosley Inc., Hair Club Co., Dermavant Sciences Inc., Histogen Inc., Capillus llc, Aclaris Therapeutics Inc., Nutrafol, Alvi Armani Co, Rogaine, Theradome Inc., Viviscal Ltd, Arena Pharmaceuticals Ltd, Cassiopea SA, Follica Inc., RepliCel Life Sciences Inc., HairClone Ltd, Revian Inc., and Nioxin.

What New Trends Are Emerging In The Alopecia Treatment Market?
Key market players are focusing on innovative solutions such as oral small-molecule Janus kinase JAK inhibitors to enhance treatment efficacy, accelerate hair regrowth, and offer targeted therapy for patients with severe or resistant forms of alopecia areata. For instance, in July 2024, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, received US FDA approval for LEQSELVI, an oral JAK inhibitor for treating adults with severe alopecia areata. This drug selectively inhibits JAK1 and JAK2 enzymes, which are implicated in the immune system's attack on hair follicles in this autoimmune disorder.

How Is The Alopecia Treatment Market Segmented?
The alopecia treatment market is segmented based on dosage form, route of administration, indication, gender type, and end-user. Subsegments include drug therapy, hair transplant services, and low-level laser therapy LLLT options.
* By Dosage Form: Drug Therapy, Hair Transplant Services, Low-Level Laser Therapy
* By Route of Administration: Topical, Injectable, Oral
* By Indication: Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Alopecia Barbae, Chemotherapy Induced Alopecia, Other Indications
* By Gender Type: Male, Female
* By End User: Hospitals And Physicians Offices, Dermatology Clinics, Other End Users
* By Drug Therapy: Topical Solutions, Oral Medications, Injectable Treatments, Immunosuppressants, Janus Kinase Inhibitors
* By Hair Transplant Services: Follicular Unit Transplantation FUT, Follicular Unit Extraction FUE, Robotic Hair Transplantation, Direct Hair Implantation DHI
* By Low-Level Laser Therapy LLLT: Laser Helmets, Laser Combs, Laser Caps, In-Clinic Laser Devices

What Are The Regional Highlights Of The Alopecia Treatment Market?
In 2024, North America held the largest share in the alopecia treatment market. However, the fastest-growing region forecasted in the period ahead is Asia-Pacific. The geographic coverage in this report spans Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:
Hair Care Stores Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hair-care-stores-global-market-report

Alopecia Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/alopecia-global-market-report

Alopecia Areata Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/alopecia-areata-global-market-report

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company is committed to offering comprehensive, data-rich research and insights. Equipped with 1,500,000 datasets, our in-depth secondary research and unique insights from industry leaders provide the information you need to stay ahead.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.